Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guy Leverger

Showing results (71-80 of 199) with videos related to

Pageof 20
Sort By:
Pediatric Blood & Cancer|September 17, 2015
A Phase I Study of Clofarabine With Multiagent Chemotherapy in Childhood High Risk Relapse of Acute Lymphoblastic Leukemia (VANDEVOL Study of the French SFCE Acute Leukemia Committee)Brigitte Nelken, Helene Cave, Guy Leverger, et al.
Cancers|August 27, 2021
Discontinuation of Imatinib in Children with Chronic Myeloid Leukemia: A Study from the International Registry of Childhood CMLFrédéric Millot, Meinolf Suttorp, Stéphanie Ragot, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 4, 2003
Outcome in children with relapsed acute myeloid leukemia after initial treatment with the French Leucemie Aique Myeloide Enfant (LAME) 89/91 protocol of the French Society of Pediatric Hematology and ImmunologyNathalie Aladjidi, Anne Auvrignon, Thierry Leblanc, et al.
The Pediatric Infectious Disease Journal|August 6, 2008
Micafungin versus liposomal amphotericin B for pediatric patients with invasive candidiasis: substudy of a randomized double-blind trialFlavio Queiroz-Telles, Eitan Berezin, Guy Leverger, et al.
American Journal of Hematology|February 24, 2017
Evaluation of the efficiency of hydroxychloroquine in treating children with immune thrombocytopenia (ITP)Ombeline Roche, Nathalie Aladjidi, Josué Rakotonjanahary, et al.
The Journal of Clinical Investigation|January 17, 2014
Thrombocytopenia-associated mutations in the ANKRD26 regulatory region induce MAPK hyperactivationDominique Bluteau, Alessandra Balduini, Nathalie Balayn, et al.
British Journal of Haematology|September 22, 2016
Management of relapsed and refractory childhood acute promyelocytic leukaemia: recommendations from an international expert panelOussama Abla, Matthew A Kutny, Anna Maria Testi, et al.
Blood|February 21, 2009
C/EBPA methylation is common in T-ALL but not in M0 AMLLouis Terriou, Raouf Ben Abdelali, Christophe Roumier, et al.
Blood|January 7, 2021
Thrombopoietin receptor agonists as an emergency treatment for severe newly diagnosed immune thrombocytopenia in childrenMarie Nolla, Nathalie Aladjidi, Thierry Leblanc, et al.
The Lancet. Haematology|October 11, 2016
Child-onset and adolescent-onset acquired thrombotic thrombocytopenic purpura with severe ADAMTS13 deficiency: a cohort study of the French national registry for thrombotic microangiopathyBérangère S Joly, Alain Stepanian, Thierry Leblanc, et al.
Pageof 20

Showing results (71-80 of 199) with videos related to

Sort By:
Pageof 20
Pediatric Blood & Cancer|September 17, 2015
A Phase I Study of Clofarabine With Multiagent Chemotherapy in Childhood High Risk Relapse of Acute Lymphoblastic Leukemia (VANDEVOL Study of the French SFCE Acute Leukemia Committee)Brigitte Nelken, Helene Cave, Guy Leverger, et al.
Cancers|August 27, 2021
Discontinuation of Imatinib in Children with Chronic Myeloid Leukemia: A Study from the International Registry of Childhood CMLFrédéric Millot, Meinolf Suttorp, Stéphanie Ragot, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 4, 2003
Outcome in children with relapsed acute myeloid leukemia after initial treatment with the French Leucemie Aique Myeloide Enfant (LAME) 89/91 protocol of the French Society of Pediatric Hematology and ImmunologyNathalie Aladjidi, Anne Auvrignon, Thierry Leblanc, et al.
The Pediatric Infectious Disease Journal|August 6, 2008
Micafungin versus liposomal amphotericin B for pediatric patients with invasive candidiasis: substudy of a randomized double-blind trialFlavio Queiroz-Telles, Eitan Berezin, Guy Leverger, et al.
American Journal of Hematology|February 24, 2017
Evaluation of the efficiency of hydroxychloroquine in treating children with immune thrombocytopenia (ITP)Ombeline Roche, Nathalie Aladjidi, Josué Rakotonjanahary, et al.
The Journal of Clinical Investigation|January 17, 2014
Thrombocytopenia-associated mutations in the ANKRD26 regulatory region induce MAPK hyperactivationDominique Bluteau, Alessandra Balduini, Nathalie Balayn, et al.
British Journal of Haematology|September 22, 2016
Management of relapsed and refractory childhood acute promyelocytic leukaemia: recommendations from an international expert panelOussama Abla, Matthew A Kutny, Anna Maria Testi, et al.
Blood|February 21, 2009
C/EBPA methylation is common in T-ALL but not in M0 AMLLouis Terriou, Raouf Ben Abdelali, Christophe Roumier, et al.
Blood|January 7, 2021
Thrombopoietin receptor agonists as an emergency treatment for severe newly diagnosed immune thrombocytopenia in childrenMarie Nolla, Nathalie Aladjidi, Thierry Leblanc, et al.
The Lancet. Haematology|October 11, 2016
Child-onset and adolescent-onset acquired thrombotic thrombocytopenic purpura with severe ADAMTS13 deficiency: a cohort study of the French national registry for thrombotic microangiopathyBérangère S Joly, Alain Stepanian, Thierry Leblanc, et al.
Pageof 20